Nutriband Inc. (NTRB)
NASDAQ: NTRBHealth CareIndustrial SpecialtiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
NTRB stock chart
Technical analysisKey statistics
All statistics- Market cap
- $59.81M
- EPS (TTM)
- -$0.53
- Dividend yield
- None
- 52-week range
- 2.80 – 9.19
- Day range
- 4.84 – 5.22
- Volume / Avg
- 7.00K / 70.61K
- Beta
- —
- Shares outstanding
- 12.16M
- Next earnings
- Dec 9, 2026
52-week range
NTRB stock today
On Nov 20, NTRB ended the session at $4.92, shedding $0.0801 (1.60%), versus the S&P 500's 3.70% decline. Trading was light, with 7.00K shares changing hands, about 10% of the average daily volume. At this level, NTRB sits in the middle of its 52-week range of $2.80 to $9.19: 46.4% below the high, set on Sep 25, 2026 and 75.7% above the low.
NTRB is up 8.4% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 2.9%. Nutriband has posted a net loss over the last twelve months (EPS of -$0.53), so its P/E ratio is not meaningful. The company is scheduled to report Oct/2026 results on Dec 9.
Summary generated from market data by MetaCap's automated system. Methodology
About Nutriband
Company profileNutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain.
- Sector
- Health Care
- Industry
- Industrial Specialties
- CEO
- Mr. Gareth Sheridan
- Headquarters
- Orlando, FL
- Website
- nutriband.com
Financial highlights
Full financialsIn fiscal 2026, Nutriband generated $2.0 million in revenue, down 4.8% from fiscal 2025, its first annual decline since 2020. Nutriband reported a net loss of $8.2 million, compared with a loss of $10.5 million a year earlier. Gross margin was 27.8% (down from 34.7%) and operating margin -408.4%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $2.04M | $2.14M | $2.09M | $2.08M | $1.42M |
| Growth | -4.81% | +2.60% | +0.27% | +46.23% | +50.70% |
| Net income | $-8.23M | $-10.48M | $-5.49M | $-4.48M | $-6.18M |
| EPS (diluted) | $-2.58 | $-0.99 | $-0.69 | $-0.53 | $-0.80 |
Analyst forecast
ForecastConsensus (1 analysts)
none
Avg. price target
$15.00+204.88%
- Strong buy 0
- Buy 1
- Hold 0
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Dec 9, 2026
- Last reported (Q2 2027)
- Sep 4, 2026
- EPS actual vs est.
- $-0.07 vs —
NTRB news
All NTRB newsNutriband peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| APTAlpha Pro Tech Ltd. | 5.96 | -4.49% | $61.17M | vs NTRB |
| COCHEnvoy Medical Inc. Class A | 6.70 | 0.00% | $51.89M | vs NTRB |
| YDDLOne and One Green Technologies. Inc Class A | 0.91 | 0.00% | $50.99M | vs NTRB |
| NTICNorthern Technologies International Corporation | 7.38 | -1.99% | $71.09M | vs NTRB |
| CNXUConexeu Sciences Inc. | 1.55 | -25.48% | $47.79M | vs NTRB |
| AGPUAxe Compute Inc. | 5.71 | -10.85% | $77.94M | vs NTRB |
| LAKELakeland Industries Inc. | 8.29 | -0.48% | $82.33M | vs NTRB |
| WBXWallbox N.V. Class A | 1.49 | -13.87% | $36.14M | vs NTRB |
Indexes, lists and sector
Nutriband stock FAQ
What is Nutriband's stock price today?
NTRB last traded at $4.92 as of Nov 20, 4:00 PM EST, down 1.60% on the day. Prices are delayed at least 15 minutes.
Does Nutriband pay a dividend?
No. Nutriband does not currently pay a regular cash dividend.
When is Nutriband's next earnings date?
Nutriband is expected to report earnings on Wednesday, December 9, 2026.
Who is Nutriband's CEO?
Mr. Gareth Sheridan is the chief executive officer of Nutriband Inc..
Has NTRB ever split its stock?
Yes. The most recent NTRB stock split was a 1166-for-1000 split on Aug 12, 2022.
What is the NTRB 52-week high?
The 52-week high for NTRB is $9.19 and the 52-week low is $2.80. The stock is currently 46.4% below its high.